O-Linked &bgr;-N-Acetylglucosamine Transferase Directs Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension

Background— Idiopathic pulmonary arterial hypertension (IPAH) is a cardiopulmonary disease characterized by cellular proliferation and vascular remodeling. A more recently recognized characteristic of the disease is the dysregulation of glucose metabolism. The primary link between altered glucose metabolism and cell proliferation in IPAH has not been elucidated. We aimed to determine the relationship between glucose metabolism and smooth muscle cell proliferation in IPAH. Methods and Results— Human IPAH and control patient lung tissues and pulmonary artery smooth muscle cells (PASMCs) were used to analyze a specific pathway of glucose metabolism, the hexosamine biosynthetic pathway. We measured the levels of O-linked &bgr;-N-acetylglucosamine modification, O-linked &bgr;-N-acetylglucosamine transferase (OGT), and O-linked &bgr;-N-acetylglucosamine hydrolase in control and IPAH cells and tissues. Our data suggest that the activation of the hexosamine biosynthetic pathway directly increased OGT levels and activity, triggering changes in glycosylation and PASMC proliferation. Partial knockdown of OGT in IPAH PASMCs resulted in reduced global O-linked &bgr;-N-acetylglucosamine modification levels and abrogated PASMC proliferation. The increased proliferation observed in IPAH PASMCs was directly impacted by proteolytic activation of the cell cycle regulator, host cell factor-1. Conclusions— Our data demonstrate that hexosamine biosynthetic pathway flux is increased in IPAH and drives OGT-facilitated PASMC proliferation through specific proteolysis and direct activation of host cell factor-1. These findings establish a novel regulatory role for OGT in IPAH, shed a new light on our understanding of the disease pathobiology, and provide opportunities to design novel therapeutic strategies for IPAH.

[1]  R. Schermuly,et al.  [Relevant issues in the pathology and pathobiology of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[2]  A. Hsi,et al.  Impact of insulin resistance on ventricular function in pulmonary arterial hypertension. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  E. Michelakis,et al.  The Metabolic Theory of Pulmonary Arterial Hypertension , 2014, Circulation research.

[4]  J. Loyd,et al.  The Genetics of Pulmonary Arterial Hypertension , 2014, Circulation research.

[5]  L. Wells,et al.  Functional O-GlcNAc modifications: Implications in molecular regulation and pathophysiology , 2014, Critical reviews in biochemistry and molecular biology.

[6]  崇行 上垣内 Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients(前立腺癌細胞におけるO-GlcNAcの過剰発現は前立腺患者の予後不良と密接に関連している) , 2014 .

[7]  R. Dweik,et al.  Modification of Hyaluronan by Heavy Chains of Inter-α-Inhibitor in Idiopathic Pulmonary Arterial Hypertension* , 2014, The Journal of Biological Chemistry.

[8]  M. Tammi,et al.  Borate-aided anion exchange high-performance liquid chromatography of uridine diphosphate-sugars in brain, heart, adipose and liver tissues. , 2014, Journal of Chromatography A.

[9]  H. Shimojo,et al.  Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients , 2013, Prostate Cancer and Prostatic Disease.

[10]  W. Herr,et al.  HCF-1 Is Cleaved in the Active Site of O-GlcNAc Transferase , 2013, Science.

[11]  Gerald W. Hart,et al.  Diabetic Hyperglycemia activates CaMKII and Arrhythmias by O linked Glycosylation , 2013, Nature.

[12]  D. Vocadlo,et al.  Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells* , 2013, The Journal of Biological Chemistry.

[13]  J. Chatham,et al.  Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart. , 2013, Life sciences.

[14]  James D. Thomas,et al.  Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. , 2013, Annals of the American Thoracic Society.

[15]  H. Bøtker,et al.  Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. , 2013, Cardiovascular research.

[16]  D. Stewart,et al.  Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension , 2013, Pulmonary circulation.

[17]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[18]  S. Erzurum,et al.  Human primary lung endothelial cells in culture. , 2012, American journal of respiratory cell and molecular biology.

[19]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[20]  N. Voelkel,et al.  Pathobiology of pulmonary arterial hypertension and right ventricular failure , 2012, European Respiratory Journal.

[21]  S. Archer,et al.  Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[22]  M. Reginato,et al.  Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis* , 2012, The Journal of Biological Chemistry.

[23]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[24]  T. Rice,et al.  Unrecognized glucose intolerance is common in pulmonary arterial hypertension. , 2010, The Journal of Heart and Lung Transplantation.

[25]  G. Hart,et al.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. , 2011, Annual review of biochemistry.

[26]  M. Rigoulet,et al.  The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. , 2011, Biochimica et biophysica acta.

[27]  W. Herr,et al.  O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1 , 2011, Cell.

[28]  H. Coller,et al.  The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.

[29]  T. Issad,et al.  O-GlcNAc modification, insulin signaling and diabetic complications. , 2010, Diabetes & metabolism.

[30]  G. Hart,et al.  Increased Expression of β-N-Acetylglucosaminidase in Erythrocytes From Individuals With Pre-diabetes and Diabetes , 2010, Diabetes.

[31]  J. Hanover,et al.  The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. , 2010, Biochimica et biophysica acta.

[32]  S. Archer,et al.  A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. , 2010, Advances in experimental medicine and biology.

[33]  C. A. de la Motte,et al.  Primary Murine Airway Smooth Muscle Cells Exposed to Poly(I,C) or Tunicamycin Synthesize a Leukocyte-adhesive Hyaluronan Matrix* , 2009, Journal of Biological Chemistry.

[34]  G. Hansmann,et al.  Insulin resistance in pulmonary arterial hypertension , 2008, European Respiratory Journal.

[35]  Reid F. Thompson,et al.  Enhanced activation of a “nutrient‐sensing” pathway with age contributes to insulin resistance , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  R. Dweik,et al.  High levels of hyaluronan in idiopathic pulmonary arterial hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[37]  Jianxin Xie,et al.  Hepatic Glucose Sensing via the CREB Coactivator CRTC2 , 2008, Science.

[38]  E. Salido,et al.  The GLUT-1 XbaI Gene Polymorphism Is Associated with Vascular Calcifications in Nondiabetic Uremic Patients , 2008, Nephron Clinical Practice.

[39]  Winship Herr,et al.  E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. , 2007, Molecular cell.

[40]  N. Taniguchi A sugar-coated switch for cellular growth and arrest. , 2007, Nature chemical biology.

[41]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[42]  Ahmad Y. Sheikh,et al.  Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-&ggr; Activation , 2007 .

[43]  Raed A Dweik,et al.  Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[44]  G. Hart,et al.  Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. , 2007, Nature.

[45]  Ahmad Y. Sheikh,et al.  Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. , 2007, Circulation.

[46]  M. Buse,et al.  Identification of the Major Site of O-Linked β-N-Acetylglucosamine Modification in the C Terminus of Insulin Receptor Substrate-1 *S , 2006, Molecular & Cellular Proteomics.

[47]  J. Hanover,et al.  The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.

[48]  G. Hart,et al.  Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress , 2004, Journal of Biological Chemistry.

[49]  W. Herr,et al.  Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF‐1 , 2003, The EMBO journal.

[50]  G. Hart,et al.  A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance , 2003, Cellular and Molecular Life Sciences CMLS.

[51]  G. Parker,et al.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Hart,et al.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2002, The Journal of Biological Chemistry.

[54]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.

[55]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[56]  J. Hanover,et al.  O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.

[57]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[58]  G. Hart,et al.  Glycosylation of the c-Myc transactivation domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Marshall,et al.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.

[60]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.